Mark Lazenby on Measuring Distress in a Patient

August 11, 2015

Mark Lazenby, PhD, APRN, FAPOS

Mark Lazenby, PhD, APRN, FAPOS, associate professor, Yale School of Nursing, discusses tools to measure distress in a patient with cancer.

Related Content:

Videos

Aaron Gerds on JAK Inhibitor Therapy for Anemic Patients With Myelofibrosis

Grace Choong and Matthew Goetz On the Impact of Adjuvant Endocrine Therapy Omission in ER+ Positive Breast Cancer

Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment Selection